|
1.
|
Smith DH, Thorp ML, Gurwitz JH, McManus DD, Goldberg RJ, Allen LA, Hsu G, Sung SH, Magid DJ, Go AS. Chronic Kidney Disease and Outcomes in Heart Failure With Preserved Versus Reduced Ejection Fraction: The Cardiovascular Research Network PRESERVE Study. Circ Cardiovasc Qual Outcomes. 2013 May 1; 6(3):333-42.
|
|
|
|
|
2.
|
Gurwitz JH, Magid DJ, Smith DH, Goldberg RJ, McManus DD, Allen LA, Saczynski JS, Thorp ML, Hsu G, Sung SH, Go AS. Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction. Am J Med. 2013 May; 126(5):393-400.
|
|
|
|
|
3.
|
Briesacher BA, Tjia J, Field T, Peterson D, Gurwitz JH. Antipsychotic use among nursing home residents. JAMA. 2013 Feb 6; 309(5):440-2.
|
|
|
|
|
4.
|
Goldberg RJ, Gurwitz JH, Saczynski JS, Hsu G, McManus DD, Magid DJ, Smith DH, Go AS. Comparison of Medication Practices in Patients With Heart Failure and Preserved Versus Those With Reduced Ejection Fraction (from the Cardiovascular Research Network [CVRN]). Am J Cardiol. 2013 May 1; 111(9):1324-9.
|
|
|
|
|
5.
|
McManus DD, Hsu G, Sung SH, Saczynski JS, Smith DH, Magid DJ, Gurwitz JH, Goldberg RJ, Go AS. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc. 2013; 2(1):e005694.
|
|
|
|
|
6.
|
Harrold LR, Briesacher BA, Peterson D, Beard A, Madden J, Zhang F, Gurwitz JH, Soumerai SB. Cost-related Medication Nonadherence in Older Patients with Rheumatoid Arthritis. J Rheumatol. 2013 Feb; 40(2):137-43.
|
|
|
|
|
7.
|
Rochon PA, Gruneir A, Gill SS, Wu W, Fischer HD, Bronskill SE, Normand SL, Austin PC, Seitz DP, Bell CM, Fu L, Lipscombe L, Anderson GM, Gurwitz JH. Older men with dementia are at greater risk than women of serious events after initiating antipsychotic therapy. J Am Geriatr Soc. 2013 Jan; 61(1):55-61.
|
|
|
|
|
8.
|
Saczynski JS, Go AS, Magid DJ, Smith DH, McManus DD, Allen L, Ogarek J, Goldberg RJ, Gurwitz JH. Patterns of Comorbidity in Older Adults with Heart Failure: The Cardiovascular Research Network PRESERVE Study. J Am Geriatr Soc. 2013 Jan; 61(1):26-33.
|
|
|
|
|
9.
|
Fischer SH, Field TS, Gagne SJ, Mazor KM, Preusse P, Reed G, Peterson D, Gurwitz JH, Tjia J. Patient completion of laboratory tests to monitor medication therapy: a mixed-methods study. J Gen Intern Med. 2013 Apr; 28(4):513-21.
|
|
|
|
|
10.
|
Masoudi FA, Go AS, Magid DJ, Cassidy-Bushrow AE, Doris JM, Fiocchi F, Garcia-Montilla R, Glenn KA, Goldberg RJ, Gupta N, Gurwitz JH, Hammill SC, Hayes JJ, Jackson N, Kadish A, Lauer M, Miller AW, Multerer D, Peterson PN, Reifler LM, Reynolds K, Saczynski JS, Schuger C, Sharma PP, Smith DH, Suits M, Sung SH, Varosy PD, Vidaillet HJ, Greenlee RT. Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice. Circ Cardiovasc Qual Outcomes. 2012 Nov 1; 5(6):e78-85.
|
|
|
|
|
11.
|
Rochon PA, Gurwitz JH. Drug shortages and clinicians: no time for complacency. Arch Intern Med. 2012 Oct 22; 172(19):1499-500.
|
|
|
|
|
12.
|
Saczynski JS, Gabbay E, McManus DD, McManus R, Gore JM, Gurwitz JH, Lessard D, Goldberg RJ. Increase in the proportion of patients hospitalized with acute myocardial infarction with do-not-resuscitate orders already in place between 2001 and 2007: a nonconcurrent prospective study. Clin Epidemiol. 2012; 4:267-74.
|
|
|
|
|
13.
|
Tjia J, Field TS, Mazor KM, Donovan JL, Kanaan AO, Reed G, Doherty P, Harrold LR, Gurwitz JH. Dementia and risk of adverse warfarin-related events in the nursing home setting. Am J Geriatr Pharmacother. 2012 Oct; 10(5):323-30.
|
|
|
|
|
14.
|
Singer S, Kitch BT, Rao SR, Bonner A, Gaudet J, Bates DW, Field TS, Gurwitz JH, Keohane C, Campbell EG. An exploration of safety climate in nursing homes. J Patient Saf. 2012 Sep; 8(3):104-24.
|
|
|
|
|
15.
|
Cutrona SL, Toh S, Iyer A, Foy S, Daniel GW, Nair VP, Ng D, Butler MG, Boudreau D, Forrow S, Goldberg R, Gore J, McManus D, Racoosin JA, Gurwitz JH. Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program. Pharmacoepidemiol Drug Saf. 2013 Jan; 22(1):40-54.
|
|
|
|
|
16.
|
Harrold LR, Peterson D, Beard AJ, Gurwitz JH, Briesacher BA. Time trends in medication use and expenditures in older patients with rheumatoid arthritis. Am J Med. 2012 Sep; 125(9):937.e9-937.e15.
|
|
|
|
|
17.
|
Gurwitz JH. The physics of geriatric pharmacotherapy: overcoming therapeutic inertia and momentum. Am J Med. 2012 Jun; 125(6):523-4.
|
|
|
|
|
18.
|
Tjia J, Gurwitz JH, Briesacher BA. Challenge of changing nursing home prescribing culture. Am J Geriatr Pharmacother. 2012 Feb; 10(1):37-46.
|
|
|
|
|
19.
|
Field TS, Garber L, Gagne SJ, Tjia J, Preusse P, Donovan JL, Kanaan AO, Gurwitz JH. Technological resources and personnel costs required to implement an automated alert system for ambulatory physicians when patients are discharged from hospitals to home. Inform Prim Care. 2012; 20(2):87-93.
|
|
|
|
|
20.
|
Andrade SE, Harrold LR, Tjia J, Cutrona SL, Saczynski JS, Dodd KS, Goldberg RJ, Gurwitz JH. A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data. Pharmacoepidemiol Drug Saf. 2012 Jan; 21 Suppl 1:100-28.
|
|
|
|
|
21.
|
Saczynski JS, Andrade SE, Harrold LR, Tjia J, Cutrona SL, Dodd KS, Goldberg RJ, Gurwitz JH. A systematic review of validated methods for identifying heart failure using administrative data. Pharmacoepidemiol Drug Saf. 2012 Jan; 21 Suppl 1:129-40.
|
|
|
|
|
22.
|
Cutrona SL, Toh S, Iyer A, Foy S, Cavagnaro E, Forrow S, Racoosin JA, Goldberg R, Gurwitz JH. Design for validation of acute myocardial infarction cases in Mini-Sentinel. Pharmacoepidemiol Drug Saf. 2012 Jan; 21 Suppl 1:274-81.
|
|
|
|
|
23.
|
Andrade SE, Lo JC, Roblin D, Fouayzi H, Connor DF, Penfold RB, Chandra M, Reed G, Gurwitz JH. Antipsychotic medication use among children and risk of diabetes mellitus. Pediatrics. 2011 Dec; 128(6):1135-41.
|
|
|
|
|
24.
|
Subramanian S, Hoover S, Wagner JL, Donovan JL, Kanaan AO, Rochon PA, Gurwitz JH, Field TS. Immediate financial impact of computerized clinical decision support for long-term care residents with renal insufficiency: a case study. J Am Med Inform Assoc. 2012 May 1; 19(3):439-42.
|
|
|
|
|
25.
|
Tjia J, Mazor KM, Field T, Doherty P, Spenard A, Gurwitz JH. Predicting nursing home adherence to a clinical trial intervention: lessons for the conduct of cluster randomized trials. J Am Geriatr Soc. 2011 Dec; 59(12):2332-6.
|
|
|
|
|
26.
|
Tjia J, Field TS, Fischer SH, Gagne SJ, Peterson DJ, Garber LD, Gurwitz JH. Quality measurement of medication monitoring in the "meaningful use" era. Am J Manag Care. 2011 Sep; 17(9):633-7.
|
|
|
|
|
27.
|
Briesacher BA, Zhao Y, Madden JM, Zhang F, Adams AS, Tjia J, Ross-Degnan D, Gurwitz JH, Soumerai SB. Medicare part d and changes in prescription drug use and cost burden: national estimates for the medicare population, 2000 to 2007. Med Care. 2011 Sep; 49(9):834-41.
|
|
|
|
|
28.
|
Tjia J, Fischer SH, Raebel MA, Peterson D, Zhao Y, Gagne SJ, Gurwitz JH, Field TS. Baseline and Follow-up Laboratory Monitoring of Cardiovascular Medications. Ann Pharmacother. 2011 Sep; 45(9):1077-84.
|
|
|
|
|
29.
|
Steinman MA, Handler SM, Gurwitz JH, Schiff GD, Covinsky KE. Beyond the prescription: medication monitoring and adverse drug events in older adults. J Am Geriatr Soc. 2011 Aug; 59(8):1513-20.
|
|
|
|
|
30.
|
Gurwitz JH. NSAIDs and atrial fibrillation. BMJ. 2011; 343:d2495.
|
|
|
|
|
31.
|
Gurwitz JH. Pharmacogenomics: is this the final chapter in the remarkable story of warfarin? J Am Med Dir Assoc. 2011 Nov; 12(9):613-4.
|
|
|
|
|
32.
|
Gurwitz JH, Goldberg RJ. Age-Based Exclusions From Cardiovascular Clinical Trials: Implications for Elderly Individuals (and for All of Us): Comment on "The Persistent Exclusion of Older Patients From Ongoing Clinical Trials Regarding Heart Failure". Arch Intern Med. 2011 Mar 28; 171(6):557-8.
|
|
|
|
|
33.
|
Walsh KE, Mazor KM, Stille CJ, Torres I, Wagner JL, Moretti J, Chysna K, Stine CD, Usmani GN, Gurwitz JH. Medication errors in the homes of children with chronic conditions. Arch Dis Child. 2011 Jun; 96(6):581-6.
|
|
|
|
|
34.
|
Dodd KS, Saczynski JS, Zhao Y, Goldberg RJ, Gurwitz JH. Exclusion of older adults and women from recent trials of acute coronary syndromes. J Am Geriatr Soc. 2011 Mar; 59(3):506-11.
|
|
|
|
|
35.
|
Field TS, Tjia J, Mazor KM, Donovan JL, Kanaan AO, Harrold LR, Reed G, Doherty P, Spenard A, Gurwitz JH. Randomized Trial of a Warfarin Communication Protocol for Nursing Homes: an SBAR-based Approach. Am J Med. 2011 Feb; 124(2):179.e1-7.
|
|
|
|
|
36.
|
Saczynski JS, Lessard D, Spencer FA, Gurwitz JH, Gore JM, Yarzebski J, Goldberg RJ. Declining length of stay for patients hospitalized with AMI: impact on mortality and readmissions. Am J Med. 2010 Nov; 123(11):1007-15.
|
|
|
|
|
37.
|
Tjia J, Field TS, Garber LD, Donovan JL, Kanaan AO, Raebel MA, Zhao Y, Fuller JC, Gagne SJ, Fischer SH, Gurwitz JH. Development and pilot testing of guidelines to monitor high-risk medications in the ambulatory setting. Am J Manag Care. 2010 Jul; 16(7):489-96.
|
|
|
|
|
38.
|
Briesacher BA, Ross-Degnan D, Wagner AK, Fouayzi H, Zhang F, Gurwitz JH, Soumerai SB. Out-of-pocket burden of health care spending and the adequacy of the Medicare Part D low-income subsidy. Med Care. 2010 Jun; 48(6):503-9.
|
|
|
|
|
39.
|
Donovan JL, Kanaan AO, Thomson MS, Rochon P, Lee M, Gavendo L, Zhao Y, Baril JL, Field TS, Gurwitz JH. Effect of clinical decision support on psychotropic medication prescribing in the long-term care setting. J Am Geriatr Soc. 2010 May; 58(5):1005-7.
|
|
|
|
|
40.
|
Briesacher BA, Soumerai SB, Field TS, Fouayzi H, Gurwitz JH. Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes. Arch Intern Med. 2010 Apr 26; 170(8):693-8.
|
|
|
|
|
41.
|
Chen Y, Briesacher BA, Field TS, Tjia J, Lau DT, Gurwitz JH. Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med. 2010 Jan 11; 170(1):89-95.
|
|
|
|
|
42.
|
Briesacher B, Ross-Degnan D, Adams A, Wagner A, Gurwitz J, Soumerai S. A new measure of medication affordability. Soc Work Public Health. 2009 Nov-Dec; 24(6):600-12.
|
|
|
|
|
43.
|
Tjia J, Mazor KM, Field T, Meterko V, Spenard A, Gurwitz JH. Nurse-physician communication in the long-term care setting: perceived barriers and impact on patient safety. J Patient Saf. 2009 Sep; 5(3):145-52.
|
|
|
|
|
44.
|
Briesacher BA, Soumerai SB, Field TS, Fouayzi H, Gurwitz JH. Nursing home residents and enrollment in Medicare Part D. J Am Geriatr Soc. 2009 Oct; 57(10):1902-7.
|
|
|
|
|
45.
|
Mazor KM, Sabin JE, Goff SL, Smith DH, Rolnick S, Roblin D, Raebel MA, Herrinton LJ, Gurwitz JH, Boudreau D, Meterko V, Dodd KS, Platt R. Cluster randomized trials to study the comparative effectiveness of therapeutics: stakeholders' concerns and recommendations. Pharmacoepidemiol Drug Saf. 2009 Jul; 18(7):554-61.
|
|
|
|
|
46.
|
Fischer MA, Keough ME, Baril JL, Saccoccio L, Mazor KM, Ladd E, Von Worley A, Gurwitz JH. Prescribers and pharmaceutical representatives: why are we still meeting? J Gen Intern Med. 2009 Jul; 24(7):795-801.
|
|
|
|
|
47.
|
Gurwitz JH. Can anticoagulation care be improved with technology? CMAJ. 2009 Apr 28; 180(9):909-10.
|
|
|
|
|
48.
|
Field TS, Rochon P, Lee M, Gavendo L, Baril JL, Gurwitz JH. Computerized clinical decision support during medication ordering for long-term care residents with renal insufficiency. J Am Med Inform Assoc. 2009 Jul-Aug; 16(4):480-5.
|
|
|
|
|
49.
|
Brown JS, Kulldorff M, Petronis KR, Reynolds R, Chan KA, Davis RL, Graham D, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R. Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations. Pharmacoepidemiol Drug Saf. 2009 Mar; 18(3):226-34.
|
|
|
|
|
50.
|
Briesacher BA, Field TS, Baril J, Gurwitz JH. Pay-for-performance in nursing homes. Health Care Financ Rev. 2009; 30(3):1-13.
|
|
|
|
|
51.
|
Walsh KE, Dodd KS, Seetharaman K, Roblin DW, Herrinton LJ, Von Worley A, Usmani GN, Baer D, Gurwitz JH. Medication errors among adults and children with cancer in the outpatient setting. J Clin Oncol. 2009 Feb 20; 27(6):891-6.
|
|
|
|
|
52.
|
Thomson MS, Gruneir A, Lee M, Baril J, Field TS, Gurwitz JH, Rochon PA. Nursing time devoted to medication administration in long-term care: clinical, safety, and resource implications. J Am Geriatr Soc. 2009 Feb; 57(2):266-72.
|
|
|
|
|
53.
|
Go AS, Yang J, Gurwitz JH, Hsu J, Lane K, Platt R. Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice. Arch Intern Med. 2008 Dec 8; 168(22):2415-21.
|
|
|
|
|
54.
|
Gurwitz JH, Field TS, Rochon P, Judge J, Harrold LR, Bell CM, Lee M, White K, LaPrino J, Erramuspe-Mainard J, DeFlorio M, Gavendo L, Baril JL, Reed G, Bates DW. Effect of computerized provider order entry with clinical decision support on adverse drug events in the long-term care setting. J Am Geriatr Soc. 2008 Dec; 56(12):2225-33.
|
|
|
|
|
55.
|
Spencer FA, Gore JM, Lessard D, Emery C, Pacifico L, Reed G, Gurwitz JH, Goldberg RJ. Venous thromboembolism in the elderly. A community-based perspective. Thromb Haemost. 2008 Nov; 100(5):780-8.
|
|
|
|
|
56.
|
Go AS, Magid DJ, Wells B, Sung SH, Cassidy-Bushrow AE, Greenlee RT, Langer RD, Lieu TA, Margolis KL, Masoudi FA, McNeal CJ, Murata GH, Newton KM, Novotny R, Reynolds K, Roblin DW, Smith DH, Vupputuri S, White RE, Olson J, Rumsfeld JS, Gurwitz JH. The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes. 2008 Nov; 1(2):138-47.
|
|
|
|
|
57.
|
Saczynski JS, Yarzebski J, Lessard D, Spencer FA, Gurwitz JH, Gore JM, Goldberg RJ. Trends in prehospital delay in patients with acute myocardial infarction (from the Worcester Heart Attack Study). Am J Cardiol. 2008 Dec 15; 102(12):1589-94.
|
|
|
|
|
58.
|
Saczynski JS, Spencer FA, Gore JM, Gurwitz JH, Yarzebski J, Lessard D, Goldberg RJ. Twenty-year trends in the incidence of stroke complicating acute myocardial infarction: Worcester Heart Attack Study. Arch Intern Med. 2008 Oct 27; 168(19):2104-10.
|
|
|
|
|
59.
|
Walsh KE, Gurwitz JH. Medical abbreviations: writing little and communicating less. Arch Dis Child. 2008 Oct; 93(10):816-7.
|
|
|
|
|
60.
|
Briesacher BA, Field TS, Baril J, Gurwitz JH. Can pay-for-performance take nursing home care to the next level? J Am Geriatr Soc. 2008 Oct; 56(10):1937-9.
|
|
|
|
|
61.
|
Magid DJ, Gurwitz JH, Rumsfeld JS, Go AS. Creating a research data network for cardiovascular disease: the CVRN. Expert Rev Cardiovasc Ther. 2008 Sep; 6(8):1043-5.
|
|
|
|
|
62.
|
Harrold LR, Li W, Yood RA, Fuller J, Gurwitz JH. Identification of patients with arthritis and arthritis-related functional limitation using administrative data. J Public Health Manag Pract. 2008 Sep-Oct; 14(5):487-97.
|
|
|
|
|
63.
|
Rochon PA, Normand SL, Gomes T, Gill SS, Anderson GM, Melo M, Sykora K, Lipscombe L, Bell CM, Gurwitz JH. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med. 2008 May 26; 168(10):1090-6.
|
|
|
|
|
64.
|
Field TS, Rochon P, Lee M, Gavendo L, Subramanian S, Hoover S, Baril J, Gurwitz J. Costs associated with developing and implementing a computerized clinical decision support system for medication dosing for patients with renal insufficiency in the long-term care setting. J Am Med Inform Assoc. 2008 Jul-Aug; 15(4):466-72.
|
|
|
|
|
65.
|
Madden JM, Graves AJ, Zhang F, Adams AS, Briesacher BA, Ross-Degnan D, Gurwitz JH, Pierre-Jacques M, Safran DG, Adler GS, Soumerai SB. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA. 2008 Apr 23; 299(16):1922-8.
|
|
|
|
|
66.
|
Wolfstadt JI, Gurwitz JH, Field TS, Lee M, Kalkar S, Wu W, Rochon PA. The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med. 2008 Apr; 23(4):451-8.
|
|
|
|
|
67.
|
Pierre-Jacques M, Safran DG, Zhang F, Ross-Degnan D, Adams AS, Gurwitz J, Rusinak D, Soumerai SB. Reliability of new measures of cost-related medication nonadherence. Med Care. 2008 Apr; 46(4):444-8.
|
|
|
|
|
68.
|
Tjia J, Briesacher BA, Soumerai SB, Pierre-Jacques M, Zhang F, Ross-Degnan D, Gurwitz JH. Medicare beneficiaries and free prescription drug samples: a national survey. J Gen Intern Med. 2008 Jun; 23(6):709-14.
|
|
|
|
|
69.
|
Goff SL, Feld A, Andrade SE, Mahoney L, Beaton SJ, Boudreau DM, Davis RL, Goodman M, Hartsfield CL, Platt R, Roblin D, Smith D, Yood MU, Dodd K, Gurwitz JH. Administrative data used to identify patients with irritable bowel syndrome. J Clin Epidemiol. 2008 Jun; 61(6):617-21.
|
|
|
|
|
70.
|
Yarzebski J, Granillo E, Spencer FA, Lessard D, Gurwitz JH, Gore JM, Goldberg RJ. Changing trends (1986-2003) in the use of lipid lowering medication in patients hospitalized with acute myocardial infarction: a community-based perspective. Int J Cardiol. 2009 Feb 6; 132(1):66-74.
|
|
|
|
|
71.
|
Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R. Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf. 2007 Dec; 16(12):1275-84.
|
|
|
|
|
72.
|
Mazor KM, Baril J, Dugan E, Spencer F, Burgwinkle P, Gurwitz JH. Patient education about anticoagulant medication: is narrative evidence or statistical evidence more effective? Patient Educ Couns. 2007 Dec; 69(1-3):145-57.
|
|
|
|
|
73.
|
Mazor KM, Sabin JE, Boudreau D, Goodman MJ, Gurwitz JH, Herrinton LJ, Raebel MA, Roblin D, Smith DH, Meterko V, Platt R. Cluster randomized trials: opportunities and barriers identified by leaders of eight health plans. Med Care. 2007 Oct; 45(10 Supl 2):S29-37.
|
|
|
|
|
74.
|
Subramanian S, Hoover S, Gilman B, Field TS, Mutter R, Gurwitz JH. Computerized physician order entry with clinical decision support in long-term care facilities: costs and benefits to stakeholders. J Am Geriatr Soc. 2007 Sep; 55(9):1451-7.
|
|
|
|
|
75.
|
Go AS, Yang J, Gurwitz JH, Hsu J, Lane K, Platt R. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure. Am J Cardiol. 2007 Aug 15; 100(4):690-6.
|
|
|
|
|
76.
|
Gill SS, Bronskill SE, Normand SL, Anderson GM, Sykora K, Lam K, Bell CM, Lee PE, Fischer HD, Herrmann N, Gurwitz JH, Rochon PA. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 2007 Jun 5; 146(11):775-86.
|
|
|
|
|
77.
|
Bambauer KZ, Safran DG, Ross-Degnan D, Zhang F, Adams AS, Gurwitz J, Pierre-Jacques M, Soumerai SB. Depression and cost-related medication nonadherence in Medicare beneficiaries. Arch Gen Psychiatry. 2007 May; 64(5):602-8.
|
|
|
|
|
78.
|
Gurwitz JH, Field TS, Radford MJ, Harrold LR, Becker R, Reed G, DeBellis K, Moldoff J, Verzier N. The safety of warfarin therapy in the nursing home setting. Am J Med. 2007 Jun; 120(6):539-44.
|
|
|
|
|
79.
|
Rochon PA, Stukel TA, Bronskill SE, Gomes T, Sykora K, Wodchis WP, Hillmer M, Kopp A, Gurwitz JH, Anderson GM. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med. 2007 Apr 9; 167(7):676-83.
|
|
|
|
|
80.
|
Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007 Jun; 22(6):864-71.
|
|
|
|
|
81.
|
Field TS, Mazor KM, Briesacher B, Debellis KR, Gurwitz JH. Adverse drug events resulting from patient errors in older adults. J Am Geriatr Soc. 2007 Feb; 55(2):271-6.
|
|
|
|
|
82.
|
Doubeni CA, Field TS, Buist DS, Korner EJ, Bigelow C, Lamerato L, Herrinton L, Quinn VP, Hart G, Hornbrook MC, Gurwitz JH, Wagner EH. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer. 2007 Feb 1; 109(3):612-20.
|
|
|
|
|
83.
|
Wagner AK, Ross-Degnan D, Gurwitz JH, Zhang F, Gilden DB, Cosler L, Soumerai SB. Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med. 2007 Jan 16; 146(2):96-103.
|
|
|
|
|
84.
|
Gurwitz JH. An interview with Jerry Gurwitz. Interview by David Bates. Jt Comm J Qual Patient Saf. 2006 Dec; 32(12):667-71.
|
|
|
|
|
85.
|
Go AS, Lee WY, Yang J, Lo JC, Gurwitz JH. Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA. 2006 Nov 1; 296(17):2105-11.
|
|
|
|
|
86.
|
Soumerai SB, Pierre-Jacques M, Zhang F, Ross-Degnan D, Adams AS, Gurwitz J, Adler G, Safran DG. Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. Arch Intern Med. 2006 Sep 25; 166(17):1829-35.
|
|
|
|
|
87.
|
Willey CJ, Andrade SE, Cohen J, Fuller JC, Gurwitz JH. Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control. Am J Manag Care. 2006 Aug; 12(8):435-40.
|
|
|
|
|
88.
|
Mazor KM, Reed GW, Yood RA, Fischer MA, Baril J, Gurwitz JH. Disclosure of medical errors: what factors influence how patients respond? J Gen Intern Med. 2006 Jul; 21(7):704-10.
|
|
|
|
|
89.
|
Doubeni C, Bigelow C, Lessard D, Spencer F, Yarzebski J, Gore J, Gurwitz J, Goldberg R. Trends and outcomes associated with angiotensin-converting enzyme inhibitors. Am J Med. 2006 Jul; 119(7):616.e9-16.
|
|
|
|
|
90.
|
Wagner AK, Chan KA, Dashevsky I, Raebel MA, Andrade SE, Lafata JE, Davis RL, Gurwitz JH, Soumerai SB, Platt R. FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf. 2006 Jun; 15(6):369-86.
|
|
|
|
|
91.
|
Doubeni CA, Field TS, Ulcickas Yood M, Rolnick SJ, Quessenberry CP, Fouayzi H, Gurwitz JH, Wei F. Patterns and predictors of mammography utilization among breast cancer survivors. Cancer. 2006 Jun 1; 106(11):2482-8.
|
|
|
|
|
92.
|
Allen LaPointe NM, Curtis LH, Chan KA, Kramer JM, Lafata JE, Gurwitz JH, Raebel MA, Platt R. Frequency of high-risk use of QT-prolonging medications. Pharmacoepidemiol Drug Saf. 2006 Jun; 15(6):361-8.
|
|
|
|
|
93.
|
Halpern MT, Khan ZM, Schmier JK, Burnier M, Caro JJ, Cramer J, Daley WL, Gurwitz J, Hollenberg NK. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension. 2006 Jun; 47(6):1039-48.
|
|
|
|
|
94.
|
Judge J, Field TS, DeFlorio M, Laprino J, Auger J, Rochon P, Bates DW, Gurwitz JH. Prescribers' responses to alerts during medication ordering in the long term care setting. J Am Med Inform Assoc. 2006 Jul-Aug; 13(4):385-90.
|
|
|
|
|
95.
|
Gurwitz JH. Serious adverse drug effects--seeing the trees through the forest. N Engl J Med. 2006 Mar 30; 354(13):1413-5.
|
|
|
|
|
96.
|
Doubeni CA, Yood RA, Emani S, Gurwitz JH. Identifying unrecognized peripheral arterial disease among asymptomatic patients in the primary care setting. Angiology. 2006 Mar-Apr; 57(2):171-80.
|
|
|
|
|
97.
|
Rochon PA, Field TS, Bates DW, Lee M, Gavendo L, Erramuspe-Mainard J, Judge J, Gurwitz JH. Clinical application of a computerized system for physician order entry with clinical decision support to prevent adverse drug events in long-term care. CMAJ. 2006 Jan 3; 174(1):52-4.
|
|
|
|
|
98.
|
Simon SR, Andrade SE, Ellis JL, Nelson WW, Gurwitz JH, Lafata JE, Davis RL, Feldstein A, Raebel MA. Baseline laboratory monitoring of cardiovascular medications in elderly health maintenance organization enrollees. J Am Geriatr Soc. 2005 Dec; 53(12):2165-9.
|
|
|
|
|
99.
|
Field TS, Gilman BH, Subramanian S, Fuller JC, Bates DW, Gurwitz JH. The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care. 2005 Dec; 43(12):1171-6.
|
|
|
|
|
100.
|
McPhillips HA, Stille CJ, Smith D, Hecht J, Pearson J, Stull J, Debellis K, Andrade S, Miller M, Kaushal R, Gurwitz J, Davis RL. Potential medication dosing errors in outpatient pediatrics. J Pediatr. 2005 Dec; 147(6):761-7.
|
|
|
|
|
101.
|
Mazor KM, Andrade SE, Auger J, Fish L, Gurwitz JH. Communicating safety information to physicians: an examination of dear doctor letters. Pharmacoepidemiol Drug Saf. 2005 Dec; 14(12):869-75.
|
|
|
|
|
102.
|
Lash TL, Gurwitz JH, Silliman RA. Physicians' assessments of adjuvant tamoxifen's effectiveness in older patients with primary breast cancer. J Am Geriatr Soc. 2005 Nov; 53(11):1889-96.
|
|
|
|
|
103.
|
Rochon PA, Field TS, Bates DW, Lee M, Gavendo L, Erramuspe-Mainard J, Judge J, Gurwitz JH. Computerized physician order entry with clinical decision support in the long-term care setting: insights from the Baycrest Centre for Geriatric Care. J Am Geriatr Soc. 2005 Oct; 53(10):1780-9.
|
|
|
|
|
104.
|
Rochon PA, Stukel TA, Sykora K, Gill S, Garfinkel S, Anderson GM, Normand SL, Mamdani M, Lee PE, Li P, Bronskill SE, Marras C, Gurwitz JH. Atypical antipsychotics and parkinsonism. Arch Intern Med. 2005 Sep 12; 165(16):1882-8.
|
|
|
|
|
105.
|
Briesacher B, Limcangco R, Simoni-Wastila L, Doshi J, Gurwitz J. Evaluation of nationally mandated drug use reviews to improve patient safety in nursing homes: a natural experiment. J Am Geriatr Soc. 2005 Jun; 53(6):991-6.
|
|
|
|
|
106.
|
Rochon PA, Gurwitz JH, Sykora K, Mamdani M, Streiner DL, Garfinkel S, Normand SL, Anderson GM. Reader's guide to critical appraisal of cohort studies: 1. Role and design. BMJ. 2005 Apr 16; 330(7496):895-7.
|
|
|
|
|
107.
|
Gurwitz JH, Field TS, Judge J, Rochon P, Harrold LR, Cadoret C, Lee M, White K, LaPrino J, Erramuspe-Mainard J, DeFlorio M, Gavendo L, Auger J, Bates DW. The incidence of adverse drug events in two large academic long-term care facilities. Am J Med. 2005 Mar; 118(3):251-8.
|
|
|
|
|
108.
|
Simon SR, Chan KA, Soumerai SB, Wagner AK, Andrade SE, Feldstein AC, Lafata JE, Davis RL, Gurwitz JH. Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc. 2005 Feb; 53(2):227-32.
|
|
|
|
|
109.
|
Andrade SE, Graham DJ, Staffa JA, Schech SD, Shatin D, La Grenade L, Goodman MJ, Platt R, Gurwitz JH, Chan KA. Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis. J Clin Epidemiol. 2005 Feb; 58(2):171-4.
|
|
|
|
|
110.
|
Sacks JJ, Harrold LR, Helmick CG, Gurwitz JH, Emani S, Yood RA. Validation of a surveillance case definition for arthritis. J Rheumatol. 2005 Feb; 32(2):340-7.
|
|
|
|
|
111.
|
Gill SS, Rochon PA, Herrmann N, Lee PE, Sykora K, Gunraj N, Normand SL, Gurwitz JH, Marras C, Wodchis WP, Mamdani M. Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ. 2005 Feb 26; 330(7489):445.
|
|
|
|
|
112.
|
Mazor KM, Simon SR, Yood RA, Martinson BC, Gunter MJ, Reed GW, Gurwitz JH. Health plan members' views on forgiving medical errors. Am J Manag Care. 2005 Jan; 11(1):49-52.
|
|
|
|
|
113.
|
Gurwitz JH. The age/gender interface in geriatric pharmacotherapy. J Womens Health (Larchmt). 2005 Jan-Feb; 14(1):68-72.
|
|
|
|
|
114.
|
Graham DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, La Grenade L, Gurwitz JH, Chan KA, Goodman MJ, Platt R. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA. 2004 Dec 1; 292(21):2585-90.
|
|
|
|
|
115.
|
Lee WY, Capra AM, Jensvold NG, Gurwitz JH, Go AS. Gender and risk of adverse outcomes in heart failure. Am J Cardiol. 2004 Nov 1; 94(9):1147-52.
|
|
|
|
|
116.
|
Gurwitz JH. Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med. 2004 Oct 11; 164(18):1957-9.
|
|
|
|
|
117.
|
Abughosh SM, Kogut SJ, Andrade SE, Larrat P, Gurwitz JH. Persistence with lipid-lowering therapy: influence of the type of lipid-lowering agent and drug benefit plan option in elderly patients. J Manag Care Pharm. 2004 Sep-Oct; 10(5):404-11.
|
|
|
|
|
118.
|
Morse AN, Labin LC, Young SB, Aronson MP, Gurwitz JH. Exclusion of elderly women from published randomized trials of stress incontinence surgery. Obstet Gynecol. 2004 Sep; 104(3):498-503.
|
|
|
|
|
119.
|
Fink AK, Gurwitz J, Rakowski W, Guadagnoli E, Silliman RA. Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer. J Clin Oncol. 2004 Aug 15; 22(16):3309-15.
|
|
|
|
|
120.
|
Field TS, Gurwitz JH, Harrold LR, Rothschild JM, Debellis K, Seger AC, Fish LS, Garber L, Kelleher M, Bates DW. Strategies for detecting adverse drug events among older persons in the ambulatory setting. J Am Med Inform Assoc. 2004 Nov-Dec; 11(6):492-8.
|
|
|
|
|
121.
|
Mazor KM, Simon SR, Gurwitz JH. Communicating with patients about medical errors: a review of the literature. Arch Intern Med. 2004 Aug 9-23; 164(15):1690-7.
|
|
|
|
|
122.
|
Field TS, Gurwitz JH, Harrold LR, Rothschild J, DeBellis KR, Seger AC, Auger JC, Garber LA, Cadoret C, Fish LS, Garber LD, Kelleher M, Bates DW. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc. 2004 Aug; 52(8):1349-54.
|
|
|
|
|
123.
|
Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Raebel MA, Roblin D, Smith DH, Yood MU, Morse AN, Platt R. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004 Aug; 191(2):398-407.
|
|
|
|
|
124.
|
Wagner AK, Zhang F, Soumerai SB, Walker AM, Gurwitz JH, Glynn RJ, Ross-Degnan D. Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med. 2004 Jul 26; 164(14):1567-72.
|
|
|
|
|
125.
|
Andrade SE, Gurwitz JH, Field TS, Kelleher M, Majumdar SR, Reed G, Black R. Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Manag Care. 2004 Jul; 10(7 Pt 2):481-6.
|
|
|
|
|
126.
|
Malek K, Fink AK, Thwin SS, Gurwitz J, Ganz PA, Silliman RA. The relationship among physicians' specialty, perceptions of the risks and benefits of adjuvant tamoxifen therapy, and its recommendation in older patients with breast cancer. Med Care. 2004 Jul; 42(7):700-6.
|
|
|
|
|
127.
|
Lane CJ, Bronskill SE, Sykora K, Dhalla IA, Anderson GM, Mamdani MM, Gill SS, Gurwitz JH, Rochon PA. Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents. J Am Geriatr Soc. 2004 Jun; 52(6):861-6.
|
|
|
|
|
128.
|
Rochon PA, Sykora K, Bronskill SE, Mamdani M, Anderson GM, Gurwitz JH, Gill S, Tu JV, Laupacis A. Use of angiotensin-converting enzyme inhibitor therapy and dose-related outcomes in older adults with new heart failure in the community. J Gen Intern Med. 2004 Jun; 19(6):676-83.
|
|
|
|
|
129.
|
Jackson EA, Yarzebski JL, Goldberg RJ, Wheeler B, Gurwitz JH, Lessard DM, Bedell SE, Gore JM. Do-not-resuscitate orders in patients hospitalized with acute myocardial infarction: the Worcester Heart Attack Study. Arch Intern Med. 2004 Apr 12; 164(7):776-83.
|
|
|
|
|
130.
|
Mazor KM, Simon SR, Yood RA, Martinson BC, Gunter MJ, Reed GW, Gurwitz JH. Health plan members' views about disclosure of medical errors. Ann Intern Med. 2004 Mar 16; 140(6):409-18.
|
|
|
|
|
131.
|
Rochon PA, Lane CJ, Bronskill SE, Sykora K, Anderson GM, Mamdani MM, Gurwitz JH, Dhalla IA. Potentially inappropriate prescribing in Canada relative to the US. Drugs Aging. 2004; 21(14):939-47.
|
|
|
|
|
132.
|
Andrade SE, Majumdar SR, Chan KA, Buist DS, Go AS, Goodman M, Smith DH, Platt R, Gurwitz JH. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med. 2003 Sep 22; 163(17):2052-7.
|
|
|
|
|
133.
|
Harrold LR, Esteban J, Lessard D, Yarzebski J, Gurwitz JH, Gore JM, Goldberg RJ. Narrowing gender differences in procedure use for acute myocardial infarction: insights from the Worcester heart attack study. J Gen Intern Med. 2003 Jun; 18(6):423-31.
|
|
|
|
|
134.
|
Simon SR, Gurwitz JH. Drug therapy in the elderly: improving quality and access. Clin Pharmacol Ther. 2003 May; 73(5):387-93.
|
|
|
|
|
135.
|
Chan KA, Truman A, Gurwitz JH, Hurley JS, Martinson B, Platt R, Everhart JE, Moseley RH, Terrault N, Ackerson L, Selby JV. A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. Arch Intern Med. 2003 Mar 24; 163(6):728-34.
|
|
|
|
|
136.
|
Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber L, Kelleher M, Bates DW. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003 Mar 5; 289(9):1107-16.
|
|
|
|
|
137.
|
Gurwitz JH. Testing medications in children. N Engl J Med. 2003 Feb 20; 348(8):763-4; author reply 763-4.
|
|
|
|
|
138.
|
Harrold LR, Lessard D, Yarzebski J, Gurwitz JH, Gore JM, Goldberg RJ. Age and sex differences in the treatment of patients with initial acute myocardial infarction: a community-wide perspective. Cardiology. 2003; 99(1):39-46.
|
|
|
|
|
139.
|
Gurwitz JH, Andrade SE. Risk management in therapeutics: when the patient becomes the last line of defense. Pharmacoepidemiol Drug Saf. 2002 Dec; 11(8):637-9.
|
|
|
|
|
140.
|
Mazor KM, Campbell EG, Field T, Purwono U, Peterson D, Lockwood JH, Weissman JS, Gurwitz JH. Managed care education: what medical students are telling us. Acad Med. 2002 Nov; 77(11):1128-33.
|
|
|
|
|
141.
|
Mazor KM, Clauser BE, Field T, Yood RA, Gurwitz JH. A demonstration of the impact of response bias on the results of patient satisfaction surveys. Health Serv Res. 2002 Oct; 37(5):1403-17.
|
|
|
|
|
142.
|
Keough ME, Field TS, Gurwitz JH. A model of community-based interdisciplinary team training in the care of the frail elderly. Acad Med. 2002 Sep; 77(9):936.
|
|
|
|
|
143.
|
Harrold LR, Yood RA, Straus W, Andrade SE, Reed JI, Cernieux J, Lewis BE, Gurwitz JH. Challenges of estimating health service utilization for osteoarthritis patients on a population level. J Rheumatol. 2002 Sep; 29(9):1931-6.
|
|
|
|
|
144.
|
Ali O, Sadiq I, Goldberg RJ, Yarzebski J, Lessard D, Gurwitz J, Gore JM. Age-specific differences in the use of thrombolytic therapy and hospital outcomes in patients with acute myocardial infarction: a community-wide perspective. J Thromb Thrombolysis. 2002 Aug; 14(1):5-14.
|
|
|
|
|
145.
|
Harrold LR, Gurwitz JH, Tate JP, Becker R, Stuart T, Elwell A, Radford M. Physician attitudes concerning anticoagulation services in the long-term care setting. J Thromb Thrombolysis. 2002 Aug; 14(1):59-64.
|
|
|
|
|
146.
|
Gurwitz JH, Rochon P. Improving the quality of medication use in elderly patients: a not-so-simple prescription. Arch Intern Med. 2002 Aug 12-26; 162(15):1670-2.
|
|
|
|
|
147.
|
Rochon PA, Bero LA, Bay AM, Gold JL, Dergal JM, Binns MA, Streiner DL, Gurwitz JH. Comparison of review articles published in peer-reviewed and throwaway journals. JAMA. 2002 Jun 5; 287(21):2853-6.
|
|
|
|
|
148.
|
Silliman RA, Guadagnoli E, Rakowski W, Landrum MB, Lash TL, Wolf R, Fink A, Ganz PA, Gurwitz J, Borbas C, Mor V. Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer. J Clin Oncol. 2002 Jun 1; 20(11):2680-8.
|
|
|
|
|
149.
|
Rochon PA, Bronskill SE, Gurwitz JH. Health care for older people. BMJ. 2002 May 25; 324(7348):1231-2.
|
|
|
|
|
150.
|
Putnam KG, Buist DS, Fishman P, Andrade SE, Boles M, Chase GA, Goodman MJ, Gurwitz JH, Platt R, Raebel MA, Arnold Chan K. Chronic disease score as a predictor of hospitalization. Epidemiology. 2002 May; 13(3):340-6.
|
|
|
|
|
151.
|
Gurwitz JH, Goldberg RJ, Malmgren JA, Barron HV, Tiefenbrunn AJ, Frederick PD, Gore JM. Hospital transfer of patients with acute myocardial infarction: the effects of age, race, and insurance type. Am J Med. 2002 May; 112(7):528-34.
|
|
|
|
|
152.
|
Donahue JG, Chan KA, Andrade SE, Beck A, Boles M, Buist DS, Carey VJ, Chandler JM, Chase GA, Ettinger B, Fishman P, Goodman M, Guess HA, Gurwitz JH, LaCroix AZ, Levin TR, Platt R. Gastric and duodenal safety of daily alendronate. Arch Intern Med. 2002 Apr 22; 162(8):936-42.
|
|
|
|
|
153.
|
Soumerai SB, McLaughlin TJ, Ross-Degnan D, Christiansen CL, Gurwitz JH. Effectiveness of thrombolytic therapy for acute myocardial infarction in the elderly: cause for concern in the old-old. Arch Intern Med. 2002 Mar 11; 162(5):561-8.
|
|
|
|
|
154.
|
Andrade SE, Gurwitz JH, Chan KA, Donahue JG, Beck A, Boles M, Buist DS, Goodman M, LaCroix AZ, Levin TR, Platt R. Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study. J Clin Epidemiol. 2002 Mar; 55(3):310-3.
|
|
|
|
|
155.
|
Andrade SE, Gurwitz JH. Drug benefit plans under managed care: to what extent do older subscribers selecting less drug coverage put themselves at increased financial risk? J Am Geriatr Soc. 2002 Jan; 50(1):178-81.
|
|
|
|
|
156.
|
Gurwitz JH, Guadagnoli E, Landrum MB, Silliman RA, Wolf R, Weeks JC. The treating physician as active gatekeeper in the recruitment of research subjects. Med Care. 2001 Dec; 39(12):1339-44.
|
|
|
|
|
157.
|
McCormick D, Gurwitz JH, Goldberg RJ, Becker R, Tate JP, Elwell A, Radford MJ. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med. 2001 Nov 12; 161(20):2458-63.
|
|
|
|
|
158.
|
Platt R, Davis R, Finkelstein J, Go AS, Gurwitz JH, Roblin D, Soumerai S, Ross-Degnan D, Andrade S, Goodman MJ, Martinson B, Raebel MA, Smith D, Ulcickas-Yood M, Chan KA. Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics. Pharmacoepidemiol Drug Saf. 2001 Aug-Sep; 10(5):373-7.
|
|
|
|
|
159.
|
Field TS, Gurwitz JH, Avorn J, McCormick D, Jain S, Eckler M, Benser M, Bates DW. Risk factors for adverse drug events among nursing home residents. Arch Intern Med. 2001 Jul 9; 161(13):1629-34.
|
|
|
|
|
160.
|
Majumdar SR, Inui TS, Gurwitz JH, Gillman MW, McLaughlin TJ, Soumerai SB. Influence of physician specialty on adoption and relinquishment of calcium channel blockers and other treatments for myocardial infarction. J Gen Intern Med. 2001 Jun; 16(6):351-9.
|
|
|
|
|
161.
|
Yood RA, Harrold LR, Fish L, Cernieux J, Emani S, Conboy E, Gurwitz JH. Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting. Arch Intern Med. 2001 May 28; 161(10):1322-7.
|
|
|
|
|
162.
|
Baldor RA, Field TS, Gurwitz JH. Using the "Question of Scruples" game to teach managed care ethics to students. Acad Med. 2001 May; 76(5):510-1.
|
|
|
|
|
163.
|
Angeja BG, Rundle AC, Gurwitz JH, Gore JM, Barron HV. Death or nonfatal stroke in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction 2. Am J Cardiol. 2001 Mar 1; 87(5):627-30, A9.
|
|
|
|
|
164.
|
Goldberg RJ, Gore JM, Thompson CA, Gurwitz JH. Recent magnitude of and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: the second national registry of myocardial infarction. Am Heart J. 2001 Jan; 141(1):65-72.
|
|
|
|
|
165.
|
Smalley W, Shatin D, Wysowski DK, Gurwitz J, Andrade SE, Goodman M, Chan KA, Platt R, Schech SD, Ray WA. Contraindicated use of cisapride: impact of food and drug administration regulatory action. JAMA. 2000 Dec 20; 284(23):3036-9.
|
|
|
|
|
166.
|
Harrold LR, Gurwitz JH, Field TS, Andrade SE, Fish LS, Jarry PD, Yood RA. The diffusion of a novel therapy into clinical practice: the case of sildenafil. Arch Intern Med. 2000 Dec 11-25; 160(22):3401-5.
|
|
|
|
|
167.
|
Andrade SE, Gurwitz JH, Cernieux J, Fish LS. Evaluation of a formulary switch from conjugated to esterified estrogens in a managed care setting. Med Care. 2000 Sep; 38(9):970-5.
|
|
|
|
|
168.
|
Rochon PA, Tu JV, Anderson GM, Gurwitz JH, Clark JP, Lau P, Szalai JP, Sykora K, Naylor CD. Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction. Lancet. 2000 Aug 19; 356(9230):639-44.
|
|
|
|
|
169.
|
Brass LM, Lichtman JH, Wang Y, Gurwitz JH, Radford MJ, Krumholz HM. Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. Stroke. 2000 Aug; 31(8):1802-11.
|
|
|
|
|
170.
|
Harrold LR, Yood RA, Andrade SE, Reed JI, Cernieux J, Straus W, Weeks M, Lewis B, Gurwitz JH. Evaluating the predictive value of osteoarthritis diagnoses in an administrative database. Arthritis Rheum. 2000 Aug; 43(8):1881-5.
|
|
|
|
|
171.
|
Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Eckler M, Benser M, Edmondson AC, Bates DW. Incidence and preventability of adverse drug events in nursing homes. Am J Med. 2000 Aug 1; 109(2):87-94.
|
|
|
|
|
172.
|
Chan KA, Andrade SE, Boles M, Buist DS, Chase GA, Donahue JG, Goodman MJ, Gurwitz JH, LaCroix AZ, Platt R. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet. 2000 Jun 24; 355(9222):2185-8.
|
|
|
|
|
173.
|
Guadagnoli E, Soumerai SB, Gurwitz JH, Borbas C, Shapiro CL, Weeks JC, Morris N. Improving discussion of surgical treatment options for patients with breast cancer: local medical opinion leaders versus audit and performance feedback. Breast Cancer Res Treat. 2000 May; 61(2):171-5.
|
|
|
|
|
174.
|
Gurwitz JH, Rochon P. Considerations in designing an ideal medication-use system: lessons from caring for the elderly. Am J Health Syst Pharm. 2000 Mar 15; 57(6):548-51.
|
|
|
|
|
175.
|
Bohn RL, Gurwitz JH, Yeomans SM, Glynn RJ, Pasquale LR, Walker AM, Avorn J. Which patients are treated for glaucoma? An observational analysis. J Glaucoma. 2000 Feb; 9(1):38-44.
|
|
|
|
|
176.
|
Barron HV, Rundle AC, Gore JM, Gurwitz JH, Penney J. Intracranial hemorrhage rates and effect of immediate beta-blocker use in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction-2. Am J Cardiol. 2000 Feb 1; 85(3):294-8.
|
|
|
|
|
177.
|
Gurwitz JH, Rochon P. Health care quality, the older patient, and the primary care physician. J Am Geriatr Soc. 1999 Dec; 47(12):1473-4.
|
|
|
|
|
178.
|
Majumdar SR, Gurwitz JH, Soumerai SB. Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease. J Gen Intern Med. 1999 Dec; 14(12):711-7.
|
|
|
|
|
179.
|
Rochon PA, Anderson GM, Tu JV, Clark JP, Gurwitz JH, Szalai JP, Lau P. Use of beta-blocker therapy in older patients after acute myocardial infarction in Ontario. CMAJ. 1999 Nov 30; 161(11):1403-8.
|
|
|
|
|
180.
|
Goldberg RJ, Gurwitz JH, Gore JM. Duration of, and temporal trends (1994-1997) in, prehospital delay in patients with acute myocardial infarction: the second National Registry of Myocardial Infarction. Arch Intern Med. 1999 Oct 11; 159(18):2141-7.
|
|
|
|
|
181.
|
McLaughlin TJ, Gurwitz JH, Willison DJ, Gao X, Soumerai SB. Delayed thrombolytic treatment of older patients with acute myocardial infarction. J Am Geriatr Soc. 1999 Oct; 47(10):1222-8.
|
|
|
|
|
182.
|
Soumerai SB, McLaughlin TJ, Gurwitz JH, Pearson S, Christiansen CL, Borbas C, Morris N, McLaughlin B, Gao X, Ross-Degnan D. Timeliness and quality of care for elderly patients with acute myocardial infarction under health maintenance organization vs fee-for-service insurance. Arch Intern Med. 1999 Sep 27; 159(17):2013-20.
|
|
|
|
|
183.
|
Rochon PA, Anderson GM, Tu JV, Gurwitz JH, Clark JP, Shear NH, Lau P. Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective dose. J Am Geriatr Soc. 1999 Aug; 47(8):954-9.
|
|
|
|
|
184.
|
Glynn RJ, Monane M, Gurwitz JH, Choodnovskiy I, Avorn J. Aging, comorbidity, and reduced rates of drug treatment for diabetes mellitus. J Clin Epidemiol. 1999 Aug; 52(8):781-90.
|
|
|
|
|
185.
|
Harrold LR, Field TS, Gurwitz JH. Knowledge, patterns of care, and outcomes of care for generalists and specialists. J Gen Intern Med. 1999 Aug; 14(8):499-511.
|
|
|
|
|
186.
|
Rochon PA, Gurwitz JH. Prescribing for seniors: neither too much nor too little. JAMA. 1999 Jul 14; 282(2):113-5.
|
|
|
|
|
187.
|
Barron HV, Rundle A, Gurwitz J, Tiefenbrunn A. Reperfusion therapy for acute myocardial infarction: observations from the National Registry of Myocardial Infarction 2. Cardiol Rev. 1999 May-Jun; 7(3):156-60.
|
|
|
|
|
188.
|
Field TS, Gurwitz JH, Glynn RJ, Salive ME, Gaziano JM, Taylor JO, Hennekens CH. The renal effects of nonsteroidal anti-inflammatory drugs in older people: findings from the Established Populations for Epidemiologic Studies of the Elderly. J Am Geriatr Soc. 1999 May; 47(5):507-11.
|
|
|
|
|
189.
|
Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999 Apr 15; 340(15):1162-8.
|
|
|
|
|
190.
|
Rochon PA, Clark JP, Gurwitz JH. Challenges of prescribing low-dose drug therapy for older people. CMAJ. 1999 Apr 6; 160(7):1029-31.
|
|
|
|
|
191.
|
Andrade SE, Gurwitz JH, Fish LS. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists. Med Care. 1999 Apr; 37(4):424-30.
|
|
|
|
|
192.
|
McCormick D, Gurwitz JH, Goldberg RJ, Ansell J. Long-term anticoagulation therapy for atrial fibrillation in elderly patients: efficacy, risk, and current patterns of use. J Thromb Thrombolysis. 1999 Apr; 7(2):157-63.
|
|
|
|
|
193.
|
McCormick D, Gurwitz JH, Lessard D, Yarzebski J, Gore JM, Goldberg RJ. Use of aspirin, beta-blockers, and lipid-lowering medications before recurrent acute myocardial infarction: missed opportunities for prevention? Arch Intern Med. 1999 Mar 22; 159(6):561-7.
|
|
|
|
|
194.
|
Glynn RJ, Monane M, Gurwitz JH, Choodnovskiy I, Avorn J. Agreement between drug treatment data and a discharge diagnosis of diabetes mellitus in the elderly. Am J Epidemiol. 1999 Mar 15; 149(6):541-9.
|
|
|
|
|
195.
|
McCormick D, Gurwitz JH, Savageau J, Yarzebski J, Gore JM, Goldberg RJ. Differences in discharge medication after acute myocardial infarction in patients with HMO and fee-for-service medical insurance. J Gen Intern Med. 1999 Feb; 14(2):73-81.
|
|
|
|
|
196.
|
Goldberg RJ, Gurwitz JH. Disseminating the results of clinical trials to community-based practitioners: is anyone listening? Am Heart J. 1999 Jan; 137(1):4-7.
|
|
|
|
|
197.
|
Lasser DH, Chuman A, Ferrara E, Gurwitz J. Use of a mini-grant program to stimulate generalist training at the University of Massachusetts Medical Center. Acad Med. 1999 Jan; 74(1 Suppl):S30-5.
|
|
|
|
|
198.
|
Goldberg RJ, McCormick D, Gurwitz JH, Yarzebski J, Lessard D, Gore JM. Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995). Am J Cardiol. 1998 Dec 1; 82(11):1311-7.
|
|
|
|
|
199.
|
Donahue JG, Andrade SE, Cain EM, Defor TA, Goodman MJ, Gurwitz J, Platt R. Lamotrigine and severe skin eruptions. Pharmacoepidemiol Drug Saf. 1998 Nov; 7(6):415-7.
|
|
|
|
|
200.
|
Gurwitz JH, Gore JM, Goldberg RJ, Barron HV, Breen T, Rundle AC, Sloan MA, French W, Rogers WJ. Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2. Ann Intern Med. 1998 Oct 15; 129(8):597-604.
|
|
|
|
|
201.
|
Willison DJ, Soumerai SB, McLaughlin TJ, Gurwitz JH, Gao X, Guadagnoli E, Pearson S, Hauptman P, McLaughlin B. Consultation between cardiologists and generalists in the management of acute myocardial infarction: implications for quality of care. Arch Intern Med. 1998 Sep 14; 158(16):1778-83.
|
|
|
|
|
202.
|
Rochon PA, Clark JP, Binns MA, Patel V, Gurwitz JH. Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction. CMAJ. 1998 Aug 25; 159(4):321-7.
|
|
|
|
|
203.
|
Goldberg RJ, Mooradd M, Gurwitz JH, Rogers WJ, French WJ, Barron HV, Gore JM. Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (The second National Registry of Myocardial Infarction). Am J Cardiol. 1998 Aug 1; 82(3):259-64.
|
|
|
|
|
204.
|
Guadagnoli E, Shapiro CL, Weeks JC, Gurwitz JH, Borbas C, Soumerai SB. The quality of care for treatment of early stage breast carcinoma: is it consistent with national guidelines? Cancer. 1998 Jul 15; 83(2):302-9.
|
|
|
|
|
205.
|
Field TS, Baldor RA, Casey LM, Chuman A, Lasser D, Ehrlich A, Gurwitz JH. Introducing managed care to the medical school curriculum: effect on student attitudes. Am J Manag Care. 1998 Jul; 4(7):1015-21.
|
|
|
|
|
206.
|
Soumerai SB, McLaughlin TJ, Gurwitz JH, Guadagnoli E, Hauptman PJ, Borbas C, Morris N, McLaughlin B, Gao X, Willison DJ, Asinger R, Gobel F. Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial. JAMA. 1998 May 6; 279(17):1358-63.
|
|
|
|
|
207.
|
Gurwitz JH, Yeomans SM, Glynn RJ, Lewis BE, Levin R, Avorn J. Patient noncompliance in the managed care setting. The case of medical therapy for glaucoma. Med Care. 1998 Mar; 36(3):357-69.
|
|
|
|
|
208.
|
Guadagnoli E, Weeks JC, Shapiro CL, Gurwitz JH, Borbas C, Soumerai SB. Use of breast-conserving surgery for treatment of stage I and stage II breast cancer. J Clin Oncol. 1998 Jan; 16(1):101-6.
|
|
|
|
|
209.
|
Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ. 1997 Oct 25; 315(7115):1096-9.
|
|
|
|
|
210.
|
Monette J, Gurwitz JH, Rochon PA, Avorn J. Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners. J Am Geriatr Soc. 1997 Sep; 45(9):1060-5.
|
|
|
|
|
211.
|
Gurwitz JH, Kalish SC, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Thiazide diuretics and the initiation of anti-gout therapy. J Clin Epidemiol. 1997 Aug; 50(8):953-9.
|
|
|
|
|
212.
|
Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens. 1997 Jul; 10(7 Pt 1):697-704.
|
|
|
|
|
213.
|
Gurwitz JH, Goldberg RJ. Coronary thrombolysis for the elderly. Is clinical practice really lagging behind evidence of benefit? JAMA. 1997 Jun 4; 277(21):1723-4.
|
|
|
|
|
214.
|
Harari D, Sarkarati M, Gurwitz JH, McGlinchey-Berroth G, Minaker KL. Constipation-related symptoms and bowel program concerning individuals with spinal cord injury. Spinal Cord. 1997 Jun; 35(6):394-401.
|
|
|
|
|
215.
|
Guadagnoli E, Shapiro C, Gurwitz JH, Silliman RA, Weeks JC, Borbas C, Soumerai SB. Age-related patterns of care: evidence against ageism in the treatment of early-stage breast cancer. J Clin Oncol. 1997 Jun; 15(6):2338-44.
|
|
|
|
|
216.
|
Gurwitz JH, Monette J, Rochon PA, Eckler MA, Avorn J. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting. Arch Intern Med. 1997 May 12; 157(9):978-84.
|
|
|
|
|
217.
|
Gurwitz JH, McLaughlin TJ, Willison DJ, Guadagnoli E, Hauptman PJ, Gao X, Soumerai SB. Delayed hospital presentation in patients who have had acute myocardial infarction. Ann Intern Med. 1997 Apr 15; 126(8):593-9.
|
|
|
|
|
218.
|
Chandra H, Yarzebski J, Goldberg RJ, Savageau J, Singleton C, Gurwitz JH, Gore JM. Age-related trends (1986-1993) in the use of thrombolytic agents in patients with acute myocardial infarction. The Worcester Heart Attack Study. Arch Intern Med. 1997 Apr 14; 157(7):741-6.
|
|
|
|
|
219.
|
Solomon DH, Gurwitz JH. Toxicity of nonsteroidal anti-inflammatory drugs in the elderly: is advanced age a risk factor? Am J Med. 1997 Feb; 102(2):208-15.
|
|
|
|
|
220.
|
Monane M, Gurwitz JH, Bohn RL, Glynn RJ, Levin R, Monette J, Avorn J. The impact of thiazide diuretics on the initiation of lipid-reducing agents in older people: a population-based analysis. J Am Geriatr Soc. 1997 Jan; 45(1):71-5.
|
|
|
|
|
221.
|
McLaughlin TJ, Soumerai SB, Willison DJ, Gurwitz JH, Gao X, Borbas C, Gobel F. The effect of comorbidity on use of thrombolysis or aspirin in patients with acute myocardial infarction eligible for treatment. J Gen Intern Med. 1997 Jan; 12(1):1-6.
|
|
|
|
|
222.
|
Harari D, Gurwitz JH, Avorn J, Bohn R, Minaker KL. How do older persons define constipation? Implications for therapeutic management. J Gen Intern Med. 1997 Jan; 12(1):63-6.
|
|
|
|
|
223.
|
Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health. 1996 Dec; 86(12):1805-8.
|
|
|
|
|
224.
|
Rochon PA, Gurwitz JH. Geriatrics. The age of women. Lancet. 1996 Dec 21-28; 348 Suppl 2:sII8.
|
|
|
|
|
225.
|
Gurwitz JH. Using pharmacoepidemiological findings to guide clinical practice: sulfonylureas and hypoglycemia in older adults. J Am Geriatr Soc. 1996 Jul; 44(7):871-2.
|
|
|
|
|
226.
|
McLaughlin TJ, Soumerai SB, Willison DJ, Gurwitz JH, Borbas C, Guadagnoli E, McLaughlin B, Morris N, Cheng SC, Hauptman PJ, Antman E, Casey L, Asinger R, Gobel F. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med. 1996 Apr 8; 156(7):799-805.
|
|
|
|
|
227.
|
Gurwitz JH, Everitt DE, Monane M, Glynn RJ, Choodnovskiy I, Beaudet MP, Avorn J. The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons. J Gerontol A Biol Sci Med Sci. 1996 Mar; 51(2):M74-9.
|
|
|
|
|
228.
|
Harari D, Gurwitz JH, Avorn J, Bohn R, Minaker KL. Bowel habit in relation to age and gender. Findings from the National Health Interview Survey and clinical implications. Arch Intern Med. 1996 Feb 12; 156(3):315-20.
|
|
|
|
|
229.
|
Gurwitz JH, Gore JM, Goldberg RJ, Rubison M, Chandra N, Rogers WJ. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction. National Registry of Myocardial Infarction. Ann Intern Med. 1996 Feb 1; 124(3):283-91.
|
|
|
|
|
230.
|
Col NF, McLaughlin TJ, Soumerai SB, Hosmer DW, Yarzebski J, Gurwitz JH, Gore JM, Goldberg RJ. The impact of clinical trials on the use of medications for acute myocardial infarction. Results of a community-based study. Arch Intern Med. 1996 Jan 8; 156(1):54-60.
|
|
|
|
|
231.
|
Avorn J, Gurwitz JH, Bohn RL, Mogun H, Monane M, Walker A. Increased incidence of levodopa therapy following metoclopramide use. JAMA. 1995 Dec 13; 274(22):1780-2.
|
|
|
|
|
232.
|
Gurwitz JH, McLaughlin TJ, Fish LS. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products. Health Serv Res. 1995 Dec; 30(5):672-85.
|
|
|
|
|
233.
|
Harari D, Gurwitz JH, Avorn J, Choodnovskiy I, Minaker KL. Correlates of regular laxative use by frail elderly persons. Am J Med. 1995 Nov; 99(5):513-8.
|
|
|
|
|
234.
|
Gurwitz JH. Start low and go slow: dosing of antipsychotic medications in elderly patients with dementia. Arch Intern Med. 1995 Oct 9; 155(18):2017-8.
|
|
|
|
|
235.
|
Kalish SC, Bohn RL, Mogun H, Glynn RJ, Gurwitz JH, Avorn J. Antipsychotic prescribing patterns and the treatment of extrapyramidal symptoms in older people. J Am Geriatr Soc. 1995 Sep; 43(9):967-73.
|
|
|
|
|
236.
|
Monette J, Gurwitz JH, Avorn J. Epidemiology of adverse drug events in the nursing home setting. Drugs Aging. 1995 Sep; 7(3):203-11.
|
|
|
|
|
237.
|
Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Intern Med. 1995 Aug 1; 123(3):195-204.
|
|
|
|
|
238.
|
Gurwitz JH. Unconventional medicine and Alzheimer's disease. J Am Geriatr Soc. 1995 Jul; 43(7):829-30.
|
|
|
|
|
239.
|
Rochon PA, Gurwitz JH. Drug therapy. Lancet. 1995 Jul 1; 346(8966):32-6.
|
|
|
|
|
240.
|
Avorn J, Bohn RL, Mogun H, Gurwitz JH, Monane M, Everitt D, Walker A. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study. Am J Med. 1995 Jul; 99(1):48-54.
|
|
|
|
|
241.
|
Monane M, Gurwitz JH, Lipsitz LA, Glynn RJ, Choodnovskiy I, Avorn J. Epidemiologic and diagnostic aspects of bacteriuria: a longitudinal study in older women. J Am Geriatr Soc. 1995 Jun; 43(6):618-22.
|
|
|
|
|
242.
|
Kalish SC, Gurwitz JH, Krumholz HM, Avorn J. A cost-effectiveness model of thrombolytic therapy for acute myocardial infarction. J Gen Intern Med. 1995 Jun; 10(6):321-30.
|
|
|
|
|
243.
|
Monane M, Glynn RJ, Gurwitz JH, Bohn RL, Levin R, Avorn J. Trends in medication choices for hypertension in the elderly. The decline of the thiazides. Hypertension. 1995 May; 25(5):1045-51.
|
|
|
|
|
244.
|
Gurwitz JH, Field TS, Glynn RJ, Manson JE, Avorn J, Taylor JO, Hennekens CH. Risk factors for non-insulin-dependent diabetes mellitus requiring treatment in the elderly. J Am Geriatr Soc. 1994 Dec; 42(12):1235-40.
|
|
|
|
|
245.
|
Ross-Degnan D, Soumerai SB, Fortess EE, Gurwitz JH. Withdrawal of a drug from the market: what should the prescriber do? JAMA. 1994 Oct 26; 272(16):1253.
|
|
|
|
|
246.
|
Gurwitz JH, Goldberg RJ, Chen Z, Gore JM, Alpert JS. Recent trends in hospital mortality of acute myocardial infarction--the Worcester Heart Attack Study. Have improvements been realized for all age groups? Arch Intern Med. 1994 Oct 10; 154(19):2202-8.
|
|
|
|
|
247.
|
Gurwitz JH, Avorn J, Bohn RL, Glynn RJ, Monane M, Mogun H. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA. 1994 Sep 14; 272(10):781-6.
|
|
|
|
|
248.
|
Harari D, Gurwitz JH, Avorn J, Choodnovskiy I, Minaker KL. Constipation: assessment and management in an institutionalized elderly population. J Am Geriatr Soc. 1994 Sep; 42(9):947-52.
|
|
|
|
|
249.
|
Gurwitz JH. Suboptimal medication use in the elderly. The tip of the iceberg. JAMA. 1994 Jul 27; 272(4):316-7.
|
|
|
|
|
250.
|
Rochon PA, Gurwitz JH, Cheung CM, Hayes JA, Chalmers TC. Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal. JAMA. 1994 Jul 13; 272(2):108-13.
|
|
|
|
|
251.
|
Avorn J, Monane M, Gurwitz JH, Glynn RJ, Choodnovskiy I, Lipsitz LA. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA. 1994 Mar 9; 271(10):751-4.
|
|
|
|
|
252.
|
Jansen RW, Gurwitz JH. Controversies surrounding the use of beta-blockers in older patients with cardiovascular disease. Drugs Aging. 1994 Mar; 4(3):175-83.
|
|
|
|
|
253.
|
Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Avorn J. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med. 1994 Feb 28; 154(4):433-7.
|
|
|
|
|
254.
|
Rochon PA, Gurwitz JH, Simms RW, Fortin PR, Felson DT, Minaker KL, Chalmers TC. A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med. 1994 Jan 24; 154(2):157-63.
|
|
|
|
|
255.
|
Col NF, Gurwitz JH, Alpert JS, Goldberg RJ. Frequency of inclusion of patients with cardiogenic shock in trials of thrombolytic therapy. Am J Cardiol. 1994 Jan 15; 73(2):149-57.
|
|
|
|
|
256.
|
Gurwitz JH, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch Intern Med. 1994 Jan 10; 154(1):97-101.
|
|
|
|
|
257.
|
Pickering TD, Gurwitz JH, Zaleznik D, Noonan JP, Avorn J. The appropriateness of oral fluoroquinolone-prescribing in the long-term care setting. J Am Geriatr Soc. 1994 Jan; 42(1):28-32.
|
|
|
|
|
258.
|
Gurwitz JH, Sanchez-Cross MT, Eckler MA, Matulis J. The epidemiology of adverse and unexpected events in the long-term care setting. J Am Geriatr Soc. 1994 Jan; 42(1):33-8.
|
|
|
|
|
259.
|
Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Choodnovskiy I, Avorn J. Topical glaucoma medications and cardiovascular risk in the elderly. Clin Pharmacol Ther. 1994 Jan; 55(1):76-83.
|
|
|
|
|
260.
|
Bohn RL, Glynn RJ, Gurwitz JH, Everitt DE, Gilden D, Avorn J. Patterns of glaucoma medication use in the elderly: 1980-1990. J Glaucoma. 1994; 3(3):259-64.
|
|
|
|
|
261.
|
Ross-Degnan D, Soumerai SB, Fortess EE, Gurwitz JH. Examining product risk in context. Market withdrawal of zomepirac as a case study. JAMA. 1993 Oct 27; 270(16):1937-42.
|
|
|
|
|
262.
|
Harari D, Gurwitz JH, Minaker KL. Constipation in the elderly. J Am Geriatr Soc. 1993 Oct; 41(10):1130-40.
|
|
|
|
|
263.
|
Glynn RJ, Gurwitz JH, Bohn RL, Monane M, Choodnovskiy I, Avorn J. Old age and race as determinants of initiation of glaucoma therapy. Am J Epidemiol. 1993 Sep 15; 138(6):395-406.
|
|
|
|
|
264.
|
Gurwitz JH, Glynn RJ, Monane M, Everitt DE, Gilden D, Smith N, Avorn J. Treatment for glaucoma: adherence by the elderly. Am J Public Health. 1993 May; 83(5):711-6.
|
|
|
|
|
265.
|
Pagley PR, Yarzebski J, Goldberg R, Chen Z, Chiriboga D, Dalen P, Gurwitz J, Alpert JS, Gore JM. Gender differences in the treatment of patients with acute myocardial infarction. A multihospital, community-based perspective. Arch Intern Med. 1993 Mar 8; 153(5):625-9.
|
|
|
|
|
266.
|
Gurwitz JH, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus. Ann Intern Med. 1993 Feb 15; 118(4):273-8.
|
|
|
|
|
267.
|
Chiriboga DE, Yarzebski J, Goldberg RJ, Chen Z, Gurwitz J, Gore JM, Alpert JS, Dalen JE. A community-wide perspective of gender differences and temporal trends in the use of diagnostic and revascularization procedures for acute myocardial infarction. Am J Cardiol. 1993 Feb 1; 71(4):268-73.
|
|
|
|
|
268.
|
Avorn J, Glynn RJ, Gurwitz JH, Bohn RL, Monane M, Everitt DE, Gilden D, Choodnovskiy I. Adverse pulmonary effects of topical Beta blockers used in the treatment of glaucoma. J Glaucoma. 1993; 2(3):158-65.
|
|
|
|
|
269.
|
Gurwitz JH, Goldberg RJ, Chen Z, Gore JM, Alpert JS. Beta-blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly. Am J Med. 1992 Dec; 93(6):605-10.
|
|
|
|
|
270.
|
Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA. 1992 Sep 16; 268(11):1417-22.
|
|
|
|
|
271.
|
Goldberg RJ, Gurwitz J, Yarzebski J, Landon J, Gore JM, Alpert JS, Dalen PM, Dalen JE. Patient delay and receipt of thrombolytic therapy among patients with acute myocardial infarction from a community-wide perspective. Am J Cardiol. 1992 Aug 15; 70(4):421-5.
|
|
|
|
|
272.
|
Gurwitz JH, Avorn J, Ross-Degnan D, Choodnovskiy I, Ansell J. Aging and the anticoagulant response to warfarin therapy. Ann Intern Med. 1992 Jun 1; 116(11):901-4.
|
|
|
|
|
273.
|
Gurwitz JH, Noonan JP, Soumerai SB. Reducing the use of H2-receptor antagonists in the long-term-care setting. J Am Geriatr Soc. 1992 Apr; 40(4):359-64.
|
|
|
|
|
274.
|
Ray WA, Gurwitz J, Decker MD, Kennedy DL. Medications and the safety of the older driver: is there a basis for concern? Hum Factors. 1992 Feb; 34(1):33-47; discussion 49-51.
|
|
|
|
|
275.
|
Gurwitz JH, Noonan JP, Sanchez M, Prather W. Barium enemas in the frail elderly. Am J Med. 1992 Jan; 92(1):41-4.
|
|
|
|
|
276.
|
Clive DM, Gurwitz JH, Rossetti RG. Potassium homeostasis with indomethacin therapy in normal subjects. Am J Kidney Dis. 1992 Jan; 19(1):16-21.
|
|
|
|
|
277.
|
Gurwitz JH, Osganian V, Goldberg RJ, Chen ZY, Gore JM, Alpert JS. Diagnostic testing in acute myocardial infarction: does patient age influence utilization patterns? The Worcester Heart Attack Study. Am J Epidemiol. 1991 Nov 1; 134(9):948-57.
|
|
|
|
|
278.
|
Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med. 1991 Jun 1; 114(11):956-66.
|
|
|
|
|
279.
|
Gurwitz JH, Goldberg RJ, Gore JM. Coronary thrombolysis for the elderly? JAMA. 1991 Apr 3; 265(13):1720-3.
|
|
|
|
|
280.
|
Gurwitz JH, Avorn J, Ross-Degnan D, Lipsitz LA. Nonsteroidal anti-inflammatory drug-associated azotemia in the very old. JAMA. 1990 Jul 25; 264(4):471-5.
|
|
|
|
|
281.
|
Gurwitz JH, Soumerai SB, Avorn J. Improving medication prescribing and utilization in the nursing home. J Am Geriatr Soc. 1990 May; 38(5):542-52.
|
|
|
|
|
282.
|
Gurwitz JH, Avorn J. Old age--is it a risk for adverse drug reactions? Agents Actions Suppl. 1990; 29:13-25.
|
|
|
|
|
283.
|
Goldberg RJ, Gore JM, Gurwitz JH, Alpert JS, Brady P, Strohsnitter W, Chen ZY, Dalen JE. The impact of age on the incidence and prognosis of initial acute myocardial infarction: the Worcester Heart Attack Study. Am Heart J. 1989 Mar; 117(3):543-9.
|
|
|
|
|
284.
|
Gurwitz JH, Goldberg RJ, Holden A, Knapic N, Ansell J. Age-related risks of long-term oral anticoagulant therapy. Arch Intern Med. 1988 Aug; 148(8):1733-6.
|
|
|
|
|
285.
|
Gurwitz J. A new tumor-holding clamp. Am J Surg. 1977 Nov; 134(5):678.
|
|
|
|
|
286.
|
GURWITZ J. Retroperitoneal myosarcoma. Conn State Med J. 1955 Sep; 19(9):734-5.
|
|
|
|
|
287.
|
GURWITZ J. The location of lymphatic injury by the use of sky-blue dye. N Engl J Med. 1954 Feb 11; 250(6):251-2.
|
|
|
|
|
288.
|
HURWITZ A, GURWITZ J. Relief of pain in chronic relapsing pancreatitis by unilateral sympathectomy. Arch Surg. 1950 Aug; 61(2):379-86.
|
|
|
|
|
289.
|
GURWITZ J, GARDY LA. Pneumothorax produced by cervical rib. Conn State Med J. 1950 May; 14(5):402-5.
|
|
|
|
|
290.
|
Gurwitz J, Hurwitz A. Treatment of Pancreatic Cysts. Ann Surg. 1948 Nov; 128(5):976-80.
|
|
|
|
|
291.
|
Gaynor WC, Gurwitz J. Experiences with 156 Penetrating Wounds of the Head. Ann Surg. 1945 Jul; 122(1):12-22.
|
|
|
|
|
292.
|
GAYNOR WC, GURWITZ J. [Not available]. An Cir (B Aires). 1945 Jul; 4:926-36, transl.
|
|
|
|
